Bill's Page Views

This Week: 29   All-Time: 51

H.Con.Res.342

1 Comments

My Vote  All Votes
AyeAyes:1
NayNays:0

Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

All Bill Titles See Full Bill Text Show All Actions

Amendments

This bill has no amendments.


Bill Status

Make a Bill Status Widget (What's this?)
IntroducedresultVoted on by House
May 06, 2008

In the News feed

May 08, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

The International Academy of Compounding Pharmacists joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342 ...

Source: Medical News Today (press release), UK
Was this article useful? Yes or No


May 07, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

"We commend all of the sponsors for standing up for women and introducing H. Con. Res. 342," said LD King. "Women with menopause suffer enough. ...

Source: PharmaLive.com (press release), PA
Was this article useful? Yes or No


May 07, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

"We commend all of the sponsors for standing up for women and introducing H. Con. Res. 342," said LD King. "Women with menopause suffer enough. ...

Source: Earthtimes (press release), UK
Was this article useful? Yes or No


1 more articles...
See highest rated news articles

Blog Coverage feed

May 09, 2008 Patients, Doctors, Pharmacists Praise Bipartisan House Resolution ...

of H. Con. Res. 342, a bipartisan resolution stating that “the Food and Drug Administration’s (FDA) new policy restricting women’s access to medications containing estriol does not serve the public interest” and calling on the FDA to ..

Source: General Health Articles
Was this article useful? Yes or No


May 08, 2008 Congress

... his own affidavits and the information supplied by him to the passport authorities – all this basic details relating to a Congress MP kept on changing from year to year Yesterday H. Con. Res. 342 was introduced by Rep. ...

Source: Congress
Was this article useful? Yes or No


May 08, 2008 FDA Approvals - Amneal Pharmaceuticals Receives US FDA Approval ...

Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used ...

Source: FDA News
Was this article useful? Yes or No


8 more posts...
See highest rated blog posts

Information made available by:

Technorati

For more info about the campaign contributions behind this bill, visit its page on Maplight.org

OpenCongress is a joint project of the Participatory Politics Foundation and the Sunlight Foundation. Questions? Comments? Contact Us

Data made available by:

Govtrack.US

Help Open Up Congress:

The OpenHouse Project